Breast Cancer
Aspirin May Offer Survival Advantage in Breast, Bladder Cancer
BY BRIELLE BENYON
Personalized Approach May Boost AI Adherence
BY ERICA DINAPOLI
HER2-Positive Breast Cancer Biomarkers: The Search Continues
BY ERICA DINAPOLI
Chemoimmunotherapy Combos Push Forward in TNBC Treatment
BY ERICA DINAPOLI
HER2-Positive Breast Cancer Treatment Continues to Change
BY BRIELLE BENYON
Managing GI AEs in Metastatic Breast Cancer
BY CONOR KILLMURRAY
New Breast Cancer Agents Put Focus on Adverse Events, Adherence
BY PATRICIA JAKEL, MN, RN, AOCN
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.